xml: <clinical_study>
    <!-- This xml conforms to an XML Schema at:
      https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
    <required_header>
      <download_date>ClinicalTrials.gov processed this data on September 20, 2023</download_date>
      <link_text>Link to the current ClinicalTrials.gov record.</link_text>
      <url>https://clinicaltrials.gov/ct2/show/NCT05974553</url>
    </required_header>
    <id_info>
      <org_study_id>D4566-R</org_study_id>
      <secondary_id>1I01RX004566-01A1</secondary_id>
      <nct_id>NCT05974553</nct_id>
    </id_info>
    <brief_title>Dialectical Behavior Therapy for Justice-Involved Veterans</brief_title>
    <official_title>Dialectical Behavior Therapy for Justice-Involved Veterans: A Randomized Clinical Trial</official_title>
    <sponsors>
      <lead_sponsor>
        <agency>VA Office of Research and Development</agency>
        <agency_class>U.S. Fed</agency_class>
      </lead_sponsor>
    </sponsors>
    <source>VA Office of Research and Development</source>
    <oversight_info>
      <has_dmc>No</has_dmc>
      <is_fda_regulated_drug>No</is_fda_regulated_drug>
      <is_fda_regulated_device>No</is_fda_regulated_device>
      <is_us_export>No</is_us_export>
    </oversight_info>
    <brief_summary>
      <textblock>
        Dialectical Behavior Therapy for Justice-Involved Veterans (DBT-J) is a comprehensive,&#xD;
        integrative program distinctively designed to address the range of mental health, substance&#xD;
        use, case management, and legal needs of Veterans with current or ongoing criminal justice&#xD;
        involvement. Data from two prior clinical trials attest to the program's feasibility and&#xD;
        acceptability and preliminarily suggest participation in the program may yield meaningful&#xD;
        improvements in risk for criminal behavior and resolution of high-priority case management&#xD;
        needs. However, continued research is needed to further investigate the program's efficacy.&#xD;
        This Phase III clinical trial aims to investigate the superiority of DBT-J over a supportive&#xD;
        group therapy treatment in decreasing risk of future criminal behavior and increasing&#xD;
        psychosocial functioning. Secondary and exploratory aims will also investigate superiority of&#xD;
        DBT-J in improving secondary treatment targets, potential differential efficacy across&#xD;
        special-interest Veteran subgroups, and long-term consequences of program participation.&#xD;
      </textblock>
    </brief_summary>
    <detailed_description>
      <textblock>
        Despite substantial efforts to curb Veteran suicide, Veterans continue to die by suicide at&#xD;
        rates that far exceed their civilian peers. To date, substantial resources have been invested&#xD;
        into understanding and treating underlying risk factors and precipitants of Veteran suicide.&#xD;
        However, criminal justice involvement remains an under-examined and under-assessed risk&#xD;
        factor for Veteran suicide. Accumulating research suggests justice-involved Veterans are a&#xD;
        high-risk, high need population, particularly within the Veterans Health Administration. For&#xD;
        example, 11% of Veteran suicides are precipitated by legal troubles; 79% of Veterans&#xD;
        receiving VA supportive housing assistance have a history of one or more arrests; and 58% of&#xD;
        Veterans receiving outpatient VHA substance use treatment have a history of three or more&#xD;
        arrests. Risk for suicide among justice-involved Veterans is particularly elevated among&#xD;
        those with co-occurring difficulties, such as mental health concerns and/or housing&#xD;
        instability. Adequately addressing Veteran suicide - both for justice-involved Veterans and&#xD;
        the broader Veteran population - therefore likely requires interventions to address the legal&#xD;
        and co-occurring difficulties of at-risk Veterans.&#xD;
  &#xD;
        Dialectical Behavior Therapy for Justice-Involved Veterans (DBT-J) is distinctively designed&#xD;
        to address these range of needs faced by justice-involved Veterans, including heightened&#xD;
        suicide risk, antisocial behaviors, mental health and substance use concerns, community-based&#xD;
        structural barriers, and case management difficulties. Combining elements of three prominent,&#xD;
        evidence-based models, DBT-J provides 16 weeks of group psychotherapy, case management&#xD;
        services, and measurement-based care to Veterans with ongoing or recent criminal justice&#xD;
        involvement. Data from two prior clinical trials attest to the feasibility and acceptability&#xD;
        of DBT-J within VHA behavioral health settings. Although preliminary, data also suggest&#xD;
        participation in DBT-J may yield meaningful reductions in risk for future criminal behavior&#xD;
        and resolution of high-priority case management needs. Continued research, however, is needed&#xD;
        to further investigate the program's efficacy.&#xD;
  &#xD;
        Toward these aims, this Phase III clinical trial will:&#xD;
  &#xD;
          1. Primary Aims 1-2: Assess the superiority of DBT-J over supportive group therapy in&#xD;
             decreasing risk of future criminal behavior and increasing psychosocial functioning.&#xD;
  &#xD;
          2. Secondary Aim: Assess the superiority of DBT-J over supportive group therapy in&#xD;
             improving secondary treatment targets (i.e., suicidal ideation, criminogenic thinking,&#xD;
             psychological distress, substance use, case management needs, quality of life,&#xD;
             resilience, suicide-related behavior, and criminal recidivism).&#xD;
  &#xD;
          3. Exploratory Aims 1-2: Assess for differential efficacy of DBT-J across high-priority JIV&#xD;
             subgroups (i.e., violent versus nonviolent most recent offense type, presence/absence of&#xD;
             a substance use disorder, and presence/absence of a severe mental illness); assess&#xD;
             long-term impact of DBT-J participation (versus participation in supportive group&#xD;
             therapy) on primary and secondary treatment targets.&#xD;
  &#xD;
        A total of 200 Veterans with current or recent involvement in the criminal justice system&#xD;
        will be recruited from the greater New York City, New York and Denver, Colorado areas to&#xD;
        participate in this clinical trial. Veterans will be randomly assigned to receive either 16&#xD;
        weeks of DBT-J or 16 weeks of supportive group therapy followed by a 36 week observational&#xD;
        period. Comprehensive assessments of Veteran risk for future criminal justice involvement,&#xD;
        psychosocial functioning, suicidal ideation, criminogenic thinking, psychological distress,&#xD;
        substance use, case management needs, quality of life, resilience, suicide-related behavior,&#xD;
        and criminal recidivism will be administered periodically throughout study completion.&#xD;
        Analyses of variance will then be used to compare study conditions on primary and secondary&#xD;
        treatment targets and to compare high-priority participant subgroups on primary and secondary&#xD;
        treatment targets.&#xD;
      </textblock>
    </detailed_description>
    <overall_status>Not yet recruiting</overall_status>
    <start_date type="Anticipated">January 1, 2024</start_date>
    <completion_date type="Anticipated">October 31, 2027</completion_date>
    <primary_completion_date type="Anticipated">April 30, 2027</primary_completion_date>
    <phase>N/A</phase>
    <study_type>Interventional</study_type>
    <has_expanded_access>No</has_expanded_access>
    <study_design_info>
      <allocation>Randomized</allocation>
      <intervention_model>Parallel Assignment</intervention_model>
      <intervention_model_description>Multisite clinical trial with parallel experimental design</intervention_model_description>
      <primary_purpose>Treatment</primary_purpose>
      <masking>Single (Outcomes Assessor)</masking>
      <masking_description>All outcomes assessors are blind to participant study condition. Participants, study providers, and investigators will not be blind to study condition.</masking_description>
    </study_design_info>
    <primary_outcome>
      <measure>Level of Service / Case Management Inventory</measure>
      <time_frame>Six times over course of 52 weeks</time_frame>
      <description>semi-structured interview assessment of risk for future criminal justice involvement; score range = 0-43, with higher scores indicating greater risk for future criminal justice involvement</description>
    </primary_outcome>
    <primary_outcome>
      <measure>Inventory of Psychosocial Functioning</measure>
      <time_frame>Six times over course of 52 weeks</time_frame>
      <description>self-report instrument measuring functional impairments in romantic relationships, family relationships, work, friendships and socializing, parenting, education, and self-care; score range = 0-100, with higher scores indicating greater impairment in psychosocial functioning</description>
    </primary_outcome>
    <secondary_outcome>
      <measure>Beck Scale for Suicidal Ideation</measure>
      <time_frame>Six times over course of 52 weeks</time_frame>
      <description>self-report instrument measuring nature, frequency, and intensity of suicidal ideation; score range = 0-38, with higher scores indicating greater severity of suicidal ideation</description>
    </secondary_outcome>
    <secondary_outcome>
      <measure>The Measure of Criminogenic Thinking Styles</measure>
      <time_frame>Three times over course of 52 weeks</time_frame>
      <description>self-report instrument measuring tendency to adopt thinking styles commonly associated with engagement in criminal behavior; score range = 65-325, with higher scores indicating greater tendency to engage in criminogenic thinking styles</description>
    </secondary_outcome>
    <secondary_outcome>
      <measure>Patient Health Questionnaire-9</measure>
      <time_frame>Six times over course of 52 weeks</time_frame>
      <description>self-report instrument measuring psychological distress; score range = 0-27, with higher scores indicating greater psychological distress</description>
    </secondary_outcome>
    <secondary_outcome>
      <measure>Alcohol Use Disorders Identification Test</measure>
      <time_frame>Six times over course of 52 weeks</time_frame>
      <description>self-report instrument measuring frequency and volume of alcohol use; score range = 0-40, with higher scores indicating more severe alcohol use</description>
    </secondary_outcome>
    <secondary_outcome>
      <measure>Drug Abuse Screening Test</measure>
      <time_frame>Six times over course of 52 weeks</time_frame>
      <description>self-report instrument measuring frequency and volume of non-alcohol related substance use; score range = 0-10, with higher scores indicating more severe drug use</description>
    </secondary_outcome>
    <secondary_outcome>
      <measure>DBT-J Case Management Checklist</measure>
      <time_frame>Six times over course of 52 weeks</time_frame>
      <description>self-report instrument measuring nature and severity of common case management difficulties; score range = 0-3, with higher scores indicating broader, more severe difficulties</description>
    </secondary_outcome>
    <secondary_outcome>
      <measure>Quality of Life Enjoyment and Satisfaction Questionnaire - Short Form</measure>
      <time_frame>Six times over course of 52 weeks</time_frame>
      <description>self-report instrument measuring quality of life and perceived satisfaction with life circumstances; score range = 16-80, with higher scores indicating greater perceived satisfaction with life circumstances</description>
    </secondary_outcome>
    <secondary_outcome>
      <measure>Connor-Davidson Resilience Scale</measure>
      <time_frame>Six times over course of 52 weeks</time_frame>
      <description>self-report instrument measuring mental and emotional resilience; score range = 0-4, with higher scores indicating greater resilience</description>
    </secondary_outcome>
    <secondary_outcome>
      <measure>suicide attempt</measure>
      <time_frame>52 weeks</time_frame>
      <description>self-reported or medical chart-documented suicide attempt</description>
    </secondary_outcome>
    <secondary_outcome>
      <measure>criminal recidivism</measure>
      <time_frame>52 weeks</time_frame>
      <description>new official record-documented arrest, violation, or order of protection filed</description>
    </secondary_outcome>
    <secondary_outcome>
      <measure>Screen for Nonsuicidal Self Injury</measure>
      <time_frame>Three times over course of 52 weeks</time_frame>
      <description>self-report instrument measuring nature and frequency of nonsuicidal self-injury; score range = 0-50, with higher scores indicating greater variation in and frequency of nonsuicidal self-injury</description>
    </secondary_outcome>
    <secondary_outcome>
      <measure>Difficulties in Emotion Regulation Scale-18</measure>
      <time_frame>Six times over course of 52 weeks</time_frame>
      <description>self-report instrument measuring difficulties in emotion regulation; score range = 18-90, with higher scores indicating greater difficulties in emotion regulation</description>
    </secondary_outcome>
    <secondary_outcome>
      <measure>Triarchic Psychopathy Measure</measure>
      <time_frame>Three times over course of 52 weeks</time_frame>
      <description>self-report instrument measuring personality traits commonly associated with psychopathy; score range = 0-3, with higher scores indicating more severe psychopathic personality traits</description>
    </secondary_outcome>
    <number_of_arms>2</number_of_arms>
    <enrollment type="Anticipated">200</enrollment>
    <condition>Criminal Behavior</condition>
    <condition>Criminal Recidivism</condition>
    <condition>Psychosocial Functioning</condition>
    <arm_group>
      <arm_group_label>Dialectical Behavior Therapy for Justice-Involved Veterans</arm_group_label>
      <arm_group_type>Experimental</arm_group_type>
      <description>16 weeks of Dialectical Behavior Therapy for Justice-Involved Veterans</description>
    </arm_group>
    <arm_group>
      <arm_group_label>Supportive Group Psychotherapy</arm_group_label>
      <arm_group_type>Active Comparator</arm_group_type>
      <description>16 weeks of supportive group psychotherapy for justice-involved Veterans</description>
    </arm_group>
    <intervention>
      <intervention_type>Behavioral</intervention_type>
      <intervention_name>Dialectical Behavior Therapy for Justice-Involved Veterans</intervention_name>
      <description>16 weeks of Dialectical Behavior Therapy for Justice-Involved Veterans, including weekly 60-minute group therapy and biweekly 30-minute individual case management</description>
      <arm_group_label>Dialectical Behavior Therapy for Justice-Involved Veterans</arm_group_label>
    </intervention>
    <intervention>
      <intervention_type>Behavioral</intervention_type>
      <intervention_name>Supportive Group Psychotherapy for Justice-Involved Veterans</intervention_name>
      <description>16 weeks of clinician-facilitated supportive group psychotherapy for justice-involved Veterans, including weekly 75-minute group psychotherapy (20 hours total intervention). All interventions delivered via telehealth.</description>
      <arm_group_label>Supportive Group Psychotherapy</arm_group_label>
    </intervention>
    <eligibility>
      <criteria>
        <textblock>
          Inclusion Criteria:&#xD;
  &#xD;
            -  Veteran aged 18+&#xD;
  &#xD;
            -  Able to provide consent&#xD;
  &#xD;
            -  Current or recent history of criminal justice involvement, defined as&#xD;
  &#xD;
                 -  (a) criminal arrest, order of protection, or incarceration within two years prior&#xD;
                    to participation and/or&#xD;
  &#xD;
                 -  (b) supervision by probation or parole at the time of participation&#xD;
  &#xD;
          Exclusion Criteria:&#xD;
  &#xD;
            -  Limited English proficiency&#xD;
  &#xD;
            -  Inability to tolerate group therapy format&#xD;
  &#xD;
            -  Enrollment in a concurrent clinical trial&#xD;
  &#xD;
            -  Current or scheduled enrollment in a DBT- or RNR-based program&#xD;
  &#xD;
            -  Prior participation in DBT-J program&#xD;
        </textblock>
      </criteria>
      <gender>All</gender>
      <minimum_age>18 Years</minimum_age>
      <maximum_age>N/A</maximum_age>
      <healthy_volunteers>No</healthy_volunteers>
    </eligibility>
    <overall_official>
      <last_name>Emily R Edwards, PhD</last_name>
      <role>Principal Investigator</role>
      <affiliation>James J. Peters Veterans Affairs Medical Center</affiliation>
    </overall_official>
    <overall_contact>
      <last_name>Emily R Edwards, PhD</last_name>
      <phone>(718) 584-9000</phone>
      <phone_ext>3865</phone_ext>
      <email>emily.edwards5@va.gov</email>
    </overall_contact>
    <location>
      <facility>
        <name>Rocky Mountain Regional VA Medical Center, Aurora, CO</name>
        <address>
          <city>Aurora</city>
          <state>Colorado</state>
          <zip>80045</zip>
          <country>United States</country>
        </address>
      </facility>
      <contact>
        <last_name>Ryan Holliday, PhD</last_name>
        <email>ryan.holliday@va.gov</email>
      </contact>
    </location>
    <location>
      <facility>
        <name>James J. Peters VA Medical Center, Bronx, NY</name>
        <address>
          <city>Bronx</city>
          <state>New York</state>
          <zip>10468-3904</zip>
          <country>United States</country>
        </address>
      </facility>
      <contact>
        <last_name>Emily R Edwards, PhD</last_name>
        <phone>718-584-9000</phone>
        <phone_ext>3865</phone_ext>
        <email>emily.edwards5@va.gov</email>
      </contact>
      <investigator>
        <last_name>Emily R Edwards, PhD</last_name>
        <role>Principal Investigator</role>
      </investigator>
    </location>
    <location_countries>
      <country>United States</country>
    </location_countries>
    <verification_date>August 2023</verification_date>
    <study_first_submitted>July 26, 2023</study_first_submitted>
    <study_first_submitted_qc>July 26, 2023</study_first_submitted_qc>
    <study_first_posted type="Actual">August 3, 2023</study_first_posted>
    <last_update_submitted>August 3, 2023</last_update_submitted>
    <last_update_submitted_qc>August 3, 2023</last_update_submitted_qc>
    <last_update_posted type="Actual">August 8, 2023</last_update_posted>
    <responsible_party>
      <responsible_party_type>Sponsor</responsible_party_type>
    </responsible_party>
    <keyword>Criminal Behavior</keyword>
    <keyword>Criminal Recidivism</keyword>
    <keyword>Psychosocial Functioning</keyword>
    <keyword>Psychotherapy</keyword>
    <keyword>Psychotherapy, Group</keyword>
    <keyword>Case Management</keyword>
    <keyword>Psychiatric Rehabilitation</keyword>
    <patient_data>
      <sharing_ipd>No</sharing_ipd>
      <ipd_description>To preserve participant confidentiality, individual participant data will not be shared with anyone outside of the immediate research team.</ipd_description>
    </patient_data>
    <!-- Results have not yet been posted for this study                                          -->
  </clinical_study>
  
  
text: download date: ClinicalTrials.gov processed this data on September 20, 2023
  link text: Link to the current ClinicalTrials.gov record.
  url: https://clinicaltrials.gov/ct2/show/NCT05974553
  org study id: D4566-R
  secondary id: 1I01RX004566-01A1
  nct id: NCT05974553
  lead sponsor: 
  has dmc: No
  is fda regulated drug: No
  is fda regulated device: No
  is us export: No
  Dialectical Behavior Therapy for Justice-Involved Veterans (DBT-J) is a comprehensive,
        integrative program distinctively designed to address the range of mental health, substance
        use, case management, and legal needs of Veterans with current or ongoing criminal justice
        involvement. Data from two prior clinical trials attest to the program's feasibility and
        acceptability and preliminarily suggest participation in the program may yield meaningful
        improvements in risk for criminal behavior and resolution of high-priority case management
        needs. However, continued research is needed to further investigate the program's efficacy.
        This Phase III clinical trial aims to investigate the superiority of DBT-J over a supportive
        group therapy treatment in decreasing risk of future criminal behavior and increasing
        psychosocial functioning. Secondary and exploratory aims will also investigate superiority of
        DBT-J in improving secondary treatment targets, potential differential efficacy across
        special-interest Veteran subgroups, and long-term consequences of program participation.
  Despite substantial efforts to curb Veteran suicide, Veterans continue to die by suicide at
        rates that far exceed their civilian peers. To date, substantial resources have been invested
        into understanding and treating underlying risk factors and precipitants of Veteran suicide.
        However, criminal justice involvement remains an under-examined and under-assessed risk
        factor for Veteran suicide. Accumulating research suggests justice-involved Veterans are a
        high-risk, high need population, particularly within the Veterans Health Administration. For
        example, 11% of Veteran suicides are precipitated by legal troubles; 79% of Veterans
        receiving VA supportive housing assistance have a history of one or more arrests; and 58% of
        Veterans receiving outpatient VHA substance use treatment have a history of three or more
        arrests. Risk for suicide among justice-involved Veterans is particularly elevated among
        those with co-occurring difficulties, such as mental health concerns and/or housing
        instability. Adequately addressing Veteran suicide - both for justice-involved Veterans and
        the broader Veteran population - therefore likely requires interventions to address the legal
        and co-occurring difficulties of at-risk Veterans.
  
        Dialectical Behavior Therapy for Justice-Involved Veterans (DBT-J) is distinctively designed
        to address these range of needs faced by justice-involved Veterans, including heightened
        suicide risk, antisocial behaviors, mental health and substance use concerns, community-based
        structural barriers, and case management difficulties. Combining elements of three prominent,
        evidence-based models, DBT-J provides 16 weeks of group psychotherapy, case management
        services, and measurement-based care to Veterans with ongoing or recent criminal justice
        involvement. Data from two prior clinical trials attest to the feasibility and acceptability
        of DBT-J within VHA behavioral health settings. Although preliminary, data also suggest
        participation in DBT-J may yield meaningful reductions in risk for future criminal behavior
        and resolution of high-priority case management needs. Continued research, however, is needed
        to further investigate the program's efficacy.
  
        Toward these aims, this Phase III clinical trial will:
  
          1. Primary Aims 1-2: Assess the superiority of DBT-J over supportive group therapy in
             decreasing risk of future criminal behavior and increasing psychosocial functioning.
  
          2. Secondary Aim: Assess the superiority of DBT-J over supportive group therapy in
             improving secondary treatment targets (i.e., suicidal ideation, criminogenic thinking,
             psychological distress, substance use, case management needs, quality of life,
             resilience, suicide-related behavior, and criminal recidivism).
  
          3. Exploratory Aims 1-2: Assess for differential efficacy of DBT-J across high-priority JIV
             subgroups (i.e., violent versus nonviolent most recent offense type, presence/absence of
             a substance use disorder, and presence/absence of a severe mental illness); assess
             long-term impact of DBT-J participation (versus participation in supportive group
             therapy) on primary and secondary treatment targets.
  
        A total of 200 Veterans with current or recent involvement in the criminal justice system
        will be recruited from the greater New York City, New York and Denver, Colorado areas to
        participate in this clinical trial. Veterans will be randomly assigned to receive either 16
        weeks of DBT-J or 16 weeks of supportive group therapy followed by a 36 week observational
        period. Comprehensive assessments of Veteran risk for future criminal justice involvement,
        psychosocial functioning, suicidal ideation, criminogenic thinking, psychological distress,
        substance use, case management needs, quality of life, resilience, suicide-related behavior,
        and criminal recidivism will be administered periodically throughout study completion.
        Analyses of variance will then be used to compare study conditions on primary and secondary
        treatment targets and to compare high-priority participant subgroups on primary and secondary
        treatment targets.
  allocation: Randomized
  intervention model: Parallel Assignment
  intervention model description: Multisite clinical trial with parallel experimental design
  primary purpose: Treatment
  masking: Single (Outcomes Assessor)
  masking description: All outcomes assessors are blind to participant study condition. Participants, study providers, and investigators will not be blind to study condition.
  measure: Level of Service / Case Management Inventory
  time frame: Six times over course of 52 weeks
  description: semi-structured interview assessment of risk for future criminal justice involvement; score range = 0-43, with higher scores indicating greater risk for future criminal justice involvement
  measure: Inventory of Psychosocial Functioning
  time frame: Six times over course of 52 weeks
  description: self-report instrument measuring functional impairments in romantic relationships, family relationships, work, friendships and socializing, parenting, education, and self-care; score range = 0-100, with higher scores indicating greater impairment in psychosocial functioning
  measure: Beck Scale for Suicidal Ideation
  time frame: Six times over course of 52 weeks
  description: self-report instrument measuring nature, frequency, and intensity of suicidal ideation; score range = 0-38, with higher scores indicating greater severity of suicidal ideation
  measure: The Measure of Criminogenic Thinking Styles
  time frame: Three times over course of 52 weeks
  description: self-report instrument measuring tendency to adopt thinking styles commonly associated with engagement in criminal behavior; score range = 65-325, with higher scores indicating greater tendency to engage in criminogenic thinking styles
  measure: Patient Health Questionnaire-9
  time frame: Six times over course of 52 weeks
  description: self-report instrument measuring psychological distress; score range = 0-27, with higher scores indicating greater psychological distress
  measure: Alcohol Use Disorders Identification Test
  time frame: Six times over course of 52 weeks
  description: self-report instrument measuring frequency and volume of alcohol use; score range = 0-40, with higher scores indicating more severe alcohol use
  measure: Drug Abuse Screening Test
  time frame: Six times over course of 52 weeks
  description: self-report instrument measuring frequency and volume of non-alcohol related substance use; score range = 0-10, with higher scores indicating more severe drug use
  measure: DBT-J Case Management Checklist
  time frame: Six times over course of 52 weeks
  description: self-report instrument measuring nature and severity of common case management difficulties; score range = 0-3, with higher scores indicating broader, more severe difficulties
  measure: Quality of Life Enjoyment and Satisfaction Questionnaire - Short Form
  time frame: Six times over course of 52 weeks
  description: self-report instrument measuring quality of life and perceived satisfaction with life circumstances; score range = 16-80, with higher scores indicating greater perceived satisfaction with life circumstances
  measure: Connor-Davidson Resilience Scale
  time frame: Six times over course of 52 weeks
  description: self-report instrument measuring mental and emotional resilience; score range = 0-4, with higher scores indicating greater resilience
  measure: suicide attempt
  time frame: 52 weeks
  description: self-reported or medical chart-documented suicide attempt
  measure: criminal recidivism
  time frame: 52 weeks
  description: new official record-documented arrest, violation, or order of protection filed
  measure: Screen for Nonsuicidal Self Injury
  time frame: Three times over course of 52 weeks
  description: self-report instrument measuring nature and frequency of nonsuicidal self-injury; score range = 0-50, with higher scores indicating greater variation in and frequency of nonsuicidal self-injury
  measure: Difficulties in Emotion Regulation Scale-18
  time frame: Six times over course of 52 weeks
  description: self-report instrument measuring difficulties in emotion regulation; score range = 18-90, with higher scores indicating greater difficulties in emotion regulation
  measure: Triarchic Psychopathy Measure
  time frame: Three times over course of 52 weeks
  description: self-report instrument measuring personality traits commonly associated with psychopathy; score range = 0-3, with higher scores indicating more severe psychopathic personality traits
  arm group label: Dialectical Behavior Therapy for Justice-Involved Veterans
  arm group type: Experimental
  description: 16 weeks of Dialectical Behavior Therapy for Justice-Involved Veterans
  arm group label: Supportive Group Psychotherapy
  arm group type: Active Comparator
  description: 16 weeks of supportive group psychotherapy for justice-involved Veterans
  intervention type: Behavioral
  intervention name: Dialectical Behavior Therapy for Justice-Involved Veterans
  description: 16 weeks of Dialectical Behavior Therapy for Justice-Involved Veterans, including weekly 60-minute group therapy and biweekly 30-minute individual case management
  arm group label: Dialectical Behavior Therapy for Justice-Involved Veterans
  intervention type: Behavioral
  intervention name: Supportive Group Psychotherapy for Justice-Involved Veterans
  description: 16 weeks of clinician-facilitated supportive group psychotherapy for justice-involved Veterans, including weekly 75-minute group psychotherapy (20 hours total intervention). All interventions delivered via telehealth.
  arm group label: Supportive Group Psychotherapy
  criteria: 
  gender: All
  minimum age: 18 Years
  maximum age: N/A
  healthy volunteers: No
  last name: Emily R Edwards, PhD
  role: Principal Investigator
  affiliation: James J. Peters Veterans Affairs Medical Center
  last name: Emily R Edwards, PhD
  phone: (718) 584-9000
  phone ext: 3865
  email: emily.edwards5@va.gov
  facility: 
  contact: 
  facility: 
  contact: 
  investigator: 
  country: United States
  responsible party type: Sponsor
  sharing ipd: No
  ipd description: To preserve participant confidentiality, individual participant data will not be shared with anyone outside of the immediate research team.